Icad narcolepsy3/14/2024 The company offers PGxOne, a clinical pharmacogenomics test that predicts how patients will respond to drug therapy based on their individual genetic makeup DNA sequencing and mutation analysis of EGFR and KRAS from patient tissue and blood to provide clinically relevant genomic information for physicians, pathologists, and clinical researchers and physician-ordered DNA tests, which assess risk for inherited high cholesterol, sudden cardiac death, and inherited diabetes in healthy adults. It operates a laboratory for the development, validation, and delivery of proprietary laboratory developed tests. Admera Health, LLC, a molecular diagnostics company, focuses on personalized medicine and non-invasive cancer testing.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |